Gentiva Gets Alternative Offer After Kindred’s Hostile Bids

Gentiva Health Services Inc. (GTIV), the home health and hospice company resisting a hostile takeover attempt from Kindred Healthcare Inc., said it was approached by another investor in the sector with a higher bid.

The alternative bidder for Gentiva said it would offer $17.25 a share in cash. Based on Gentiva’s outstanding shares of about 36.8 million, the equity value of the deal would be $634.8 million. The company’s board said it would review this new proposal, without naming the bidder.

Gentiva rose 16 percent to $17.96 at 4 p.m. in New York trading, its highest price since July 2011 and giving it a market capitalization about $662 million.

Kindred offered this week to buy a 14.9 percent stake in Gentiva after the company rebuffed two takeover bids, a change in strategy to try to force the company to enter talks. That’s the most Kindred can buy without triggering a “poison pill” takeover defense as it seeks to force a deal with Gentiva.

Kindred’s current offer “significantly undervalues Gentiva’s shares, is coercive and not in the best interests of Gentiva stockholders,” said Atlanta-based Gentiva, while recommending that shareholders reject Kindred’s offer and not tender their shares.

A Kindred spokeswoman couldn’t be immediately reached for comment.

Kindred, a long-term medical care provider based in Louisville, Kentucky, would walk away if the new proposal isn’t successful in forcing talks, said Chief Executive Officer Paul Diaz in a July 14 statement. Gentiva also turned down a June offer from Kindred of $14.50 a share for the company, valued at $573 million, and an offer of $14 a share, or about $533 million, announced May 15.

To contact the reporter on this story: Sonali Basak in New York at

To contact the editors responsible for this story: Reg Gale at Drew Armstrong

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.